References
- Guo H, Zhao L, Wang B, et al. Remote limb ischemic postconditioning protects against cerebral ischemia-reperfusion injury by activating AMPK-dependent autophagy. Brain Res Bull. 2018;139:105–113. doi:https://doi.org/10.1016/j.brainresbull.2018.02.013.
- Liang D, He XB, Wang Z, et al. Remote limb ischemic postconditioning promotes motor function recovery in a rat model of ischemic stroke via the up-regulation of endogenous tissue kallikrein. CNS Neurosci Ther. 2018;24:519–527. doi:https://doi.org/10.1111/cns.12813.
- Chen G, Ye X, Zhang J, et al. Limb remote ischemic postconditioning reduces ischemia-reperfusion injury by inhibiting NADPH oxidase activation and MyD88-TRAF6-P38MAP-kinase pathway of neutrophils. Int J Mol Sci. 2016;17; doi:https://doi.org/10.3390/ijms17121971.
- Magnani F, Nenci S, Millana Fananas E, et al. Crystal structures and atomic model of NADPH oxidase. Proc Natl Acad Sci U S A. 2017;114:6764–6769. doi:https://doi.org/10.1073/pnas.1702293114.
- Zitta K, Meybohm P, Bein B, et al. Serum from patients undergoing remote ischemic preconditioning protects cultured human intestinal cells from hypoxia-induced damage: involvement of matrixmetalloproteinase-2 and -9. Mol Med. 2012;18:29–37. doi:https://doi.org/10.2119/molmed.2011.00278.
- Weber NC, Riedemann I, Smit KF, et al. Plasma from human volunteers subjected to remote ischemic preconditioning protects human endothelial cells from hypoxia-induced cell damage. Basic Res Cardiol. 2015;110:17, doi:https://doi.org/10.1007/s00395-015-0474-9.
- Xu T, Cai Y, Zhong X, et al. β-Galactosidase instructed supramolecular hydrogelation for selective identification and removal of senescent cells. Chem Commun (Camb). 2019;55:7175–7178. doi:https://doi.org/10.1039/c9cc03056e.
- Ye W, Zhong Z, Zhu S, et al. Advanced oxidation protein products induce catabolic effect through oxidant-dependent activation of NF-κ B pathway in human chondrocyte. Int Immunopharmacol. 2016;39:149–157. doi:https://doi.org/10.1016/j.intimp.2016.07.018.
- Vorobjeva N, Prikhodko A, Galkin I, et al. Mitochondrial reactive oxygen species are involved in chemoattractant-induced oxidative burst and degranulation of human neutrophils in vitro. Eur J Cell Biol. 2017;96:254–265. doi:https://doi.org/10.1016/j.ejcb.2017.03.003.
- Xia L, Zhou H, Wang T, et al. Activation of mTOR is involved in anti-β2GPI/β2GPI-induced expression of tissue factor and IL-8 in monocytes. Thromb Res. 2017;157:103–110. doi:https://doi.org/10.1016/j.thromres.2017.05.023.
- Wolf ST, Jablonski NG, Ferguson SB, et al. Four weeks of vitamin D supplementation improves nitric oxide-mediated microvascular function in college-aged African Americans. Am J Physiol Heart Circ Physiol. 2020;319:H906–906H914. doi:https://doi.org/10.1152/ajpheart.00631.2020.
- Shi B, Song D, Xue H, et al. Abnormal expression of the peptide transporter PepT1 in the colon of massive bowel resection rat: a potential route for colonic mucosa damage by transport of fMLP. Dig Dis Sci. 2006;51:2087–2093. doi:https://doi.org/10.1007/s10620-005-9067-z.
- Pillay J, den Braber I, Vrisekoop N, et al. In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood. 2010;116:625–627. doi:https://doi.org/10.1182/blood-2010-01-259028.
- Day RB, Link DC. Regulation of neutrophil trafficking from the bone marrow. Cell Mol Life Sci. 2012;69:1415–1423. doi:https://doi.org/10.1007/s00018-011-0870-8.
- Boxio R, Bossenmeyer-Pourié C, Steinckwich N, et al. Mouse bone marrow contains large numbers of functionally competent neutrophils. J Leukoc Biol. 2004;75:604–611. doi:https://doi.org/10.1189/jlb.0703340.
- Jiang M, Ni J, Cao Y, et al. Astragaloside IV attenuates Myocardial ischemia-reperfusion injury from oxidative stress by regulating succinate, lysophospholipid metabolism, and ROS scavenging system. Oxid Med Cell Longev. 2019;2019:9137654), doi:https://doi.org/10.1155/2019/9137654.
- Jun JH, Shim JK, Oh JE, et al. Protective effect of ethyl pyruvate against Myocardial Ischemia reperfusion injury through regulations of ROS-related NLRP3 inflammasome activation. Oxid Med Cell Longev. 2019;2019:4264580), doi:https://doi.org/10.1155/2019/4264580.
- Wallert M, Ziegler M, Wang X, et al. α-Tocopherol preserves cardiac function by reducing oxidative stress and inflammation in ischemia/reperfusion injury. Redox Biol. 2019;26:101292. doi:https://doi.org/10.1016/j.redox.2019.101292.
- Yang Z, Sharma AK, Marshall M, et al. NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. Am J Respir Cell Mol Biol. 2009;40:375–381. doi:https://doi.org/10.1165/rcmb.2008-0300OC.
- Sun L, Wu Q, Nie Y, et al. A role for MK2 in enhancing neutrophil-derived ROS production and aggravating liver ischemia/reperfusion injury. Front Immunol. 2018;9:2610), doi:https://doi.org/10.3389/fimmu.2018.02610.
- Yao J, Zheng J, Cai J, et al. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate rat hepatic ischemia-reperfusion injury by suppressing oxidative stress and neutrophil inflammatory response. FASEB J. 2019;33:1695–1710. doi:https://doi.org/10.1096/fj.201800131RR.
- Wang G, Weng YC, Han X, et al. Lipocalin-2 released in response to cerebral ischaemia mediates reperfusion injury in mice. J Cell Mol Med. 2015;19:1637–1645. doi:https://doi.org/10.1111/jcmm.12538.
- Zarisfi M, Allahtavakoli F, Hassanipour M, et al. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model. Brain Res Bull. 2017;134:85–90. doi:https://doi.org/10.1016/j.brainresbull.2017.07.007.
- Chen QF, Liu YY, Pan CS, et al. Angioedema and hemorrhage after 4.5-hour tPA (tissue-type plasminogen activator) Thrombolysis ameliorated by T541 via restoring brain microvascular integrity. Stroke. 2018;49:2211–2219. doi:https://doi.org/10.1161/STROKEAHA.118.021754.
- Lerario MP, Grotta JC, Merkler AE, et al. Association between intravenous Thrombolysis and anaphylaxis Among medicare beneficiaries With acute ischemic stroke. Stroke. 2019;50:3283–3285. STROKEAHA119026861. doi:https://doi.org/10.1161/STROKEAHA.119.026861.
- Gao Y, Song J, Chen H, et al. TRPV1 activation is involved in the cardioprotection of remote limb ischemic postconditioning in ischemia-reperfusion injury rats. Biochem Biophys Res Commun. 2015;463:1034–1039. doi:https://doi.org/10.1016/j.bbrc.2015.06.054.
- Zhou CC, Yao WT, Ge YZ, et al. Remote ischemic conditioning for the prevention of contrast-induced acute kidney injury in patients undergoing intravascular contrast administration: a meta-analysis and trial sequential analysis of 16 randomized controlled trials. Oncotarget. 2017;8:79323–79336. doi:https://doi.org/10.18632/oncotarget.18106.
- Chen G, Yang J, Lu G, et al. Limb remote ischemic post-conditioning reduces brain reperfusion injury by reversing eNOS uncoupling. Indian J Exp Biol. 2014;52:597–605.
- Gao S, Zhan L, Yang Z, et al. Remote limb ischaemic postconditioning protects against Myocardial ischaemia/reperfusion injury in mice: activation of JAK/STAT3-mediated Nrf2-antioxidant signalling. Cell Physiol Biochem. 2017;43:1140–1151. doi:https://doi.org/10.1159/000481755.
- Li P, Su L, Li X, et al. Remote limb ischemic postconditioning protects mouse brain against cerebral ischemia/reperfusion injury via upregulating expression of Nrf2, HO-1 and NQO-1 in mice. Int J Neurosci. 2015;126:1–8. doi:https://doi.org/10.3109/00207454.2015.1042973.
- Cheng Z, Li L, Mo X, et al. Non-invasive remote limb ischemic postconditioning protects rats against focal cerebral ischemia by upregulating STAT3 and reducing apoptosis. Int J Mol Med. 2014;34:957–966. doi:https://doi.org/10.3892/ijmm.2014.1873.
- Kim YH, Yoon DW, Kim JH, et al. Effect of remote ischemic post-conditioning on systemic inflammatory response and survival rate in lipopolysaccharide-induced systemic inflammation model. J Inflamm (Lond). 2014;11:16. doi:https://doi.org/10.1186/1476-9255-11-16.
- Li HX, Cui XL, Xue FS, et al. Inhibition of glycogen synthase kinase-3β is involved in cardioprotection by α7nAChR agonist and limb remote ischemic postconditionings. Biosci Rep. 2018;38. doi:https://doi.org/10.1042/BSR20181315.
- Mitchell TS, Moots RJ, Wright HL. Janus kinase inhibitors prevent migration of rheumatoid arthritis neutrophils towards interleukin-8, but do not inhibit priming of the respiratory burst or reactive oxygen species production. Clin Exp Immunol. 2017;189:250–258. doi:https://doi.org/10.1111/cei.12970.
- Levert H, Gressier B, Moutard I, et al. Azithromycin impact on neutrophil oxidative metabolism depends on exposure time. Inflammation. 1998;22:191–201. doi:https://doi.org/10.1023/a:1022340107017.
- el Benna J, Faust LP, Babior BM. The phosphorylation of the respiratory burst oxidase component p47phox during neutrophil activation. phosphorylation of sites recognized by protein kinase C and by proline-directed kinases. J Biol Chem. 1994;269:23431–23436.
- Cui YD, Inanami O, Yamamori T, et al. FMLP-induced formation of F-actin in HL60 cells is dependent on PI3-K but not on intracellular Ca2+, PKC, ERK or p38 MAPK. Inflamm Res. 2000;49:684–691. doi:https://doi.org/10.1007/s000110050647.
- Dang PM, Elbim C, Marie JC, et al. Anti-inflammatory effect of interleukin-10 on human neutrophil respiratory burst involves inhibition of GM-CSF-induced p47PHOX phosphorylation through a decrease in ERK1/2 activity. FASEB J. 2006;20:1504–1506. doi:https://doi.org/10.1096/fj.05-5395fje.